The expanded intervention study with Jusvinza in patients with rheumatoid arthritis (RA) with moderate to severe activity is scheduled to culminate next March in the eastern provinces and Camagüey, whose clinical site is the Lucía Iñiguez Landín hospital, in Holguín.
Cuban Prime Minister Manuel Marrero held talks today with companies from the United Arab Emirates (UAE) interested in commercializing Cuban biotechnological products, such as Heberprot-P and Melagenia Plus.
COVID-19 has not gone away, warned Dr. María Eugenia Escobar Pérez, a Second Degree specialist in Hygiene and Epidemiology, while recalling that pandemics come and go, but the viruses that cause them remain with low circulation.
Although since 1993, with the reduction in Cuba of the prevalence rate of leprosy to 0.79 per 10 thousand inhabitants, the elimination of this disease as a health problem was achieved, new cases are reported each year.
A project aimed at preventing teenage pregnancy is under way in the province of Holguín as part of the cross-sectional Mother and Child Program (PAMI).